Corpus Intelligence IC Memo — KIOWA COUNTY MEMORIAL HOSPTIAL 2026-04-26 15:55 UTC
IC Memo — KIOWA COUNTY MEMORIAL HOSPTIAL
Investment Committee Memorandum | KS | 15 beds | Grade C | EBITDA uplift $559K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KIOWA COUNTY MEMORIAL HOSPTIAL

CCN 171332 | KIOWA, KS | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KIOWA COUNTY MEMORIAL HOSPTIAL is a 15-bed safety-net/medicaid heavy in KIOWA, KS with $7.5M in net patient revenue and a -42.9% operating margin. The hospital serves a payer mix of 22.8% Medicare, 34.6% Medicaid, and 42.6% commercial.

Thesis: Turnaround. Our ML models identify $559K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -42.9% to -35.4% (+748bps).

Net Revenue HCRIS$7.5M
Current EBITDA COMPUTED$-3.2M
Operating Margin COMPUTED-42.9%
Occupancy HCRIS39.3%
Revenue / Bed COMPUTED$499K
Net-to-Gross HCRIS131.8%
Distress Probability ML66.0%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
99
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -42.9% places it below the state median. Among 99 size-comparable peers (8-30 beds), the median margin is -20.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 99 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KIOWA COUNTY MEMORIAL HOSPTIAL (Target)KS15$7.5M-42.9%
KANSAS CITY ORTHOPAEDIC INSTITKS17$86.3M21.1%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%
UKHS GREAT BEND CAMPUSKS29$53.8M-22.8%
NEOSHO MEMORIAL REGIONAL MED CKS21$53.8M-13.0%
ATCHISON HOSPITAL ASSOCIATIONKS25$50.3M-11.7%
CITIZENS MEDICAL CENTERKS23$49.5M-13.9%
WILLIAM NEWTON MEMORIAL HOSPITKS23$42.2M-20.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $559K (748bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$157K+210bp18mo
Denial Rate Reduction12.0%6.5%$152K+204bp12mo
Cost to Collect4.5%2.5%$150K+200bp12mo
A/R Days Reduction5200.0%3800.0%$91K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+13bp6mo

5. EBITDA Bridge

Net Collection Rate
$157K
Denial Rate Reduction
$152K
Cost to Collect
$150K
A/R Days Reduction
$91K
Clean Claim Rate
$10K
Total EBITDA Uplift$559K
Current EBITDA$-3.2M
+ RCM Uplift+$559K
Pro Forma EBITDA$-2.6M
Current Margin-42.9%
Pro Forma Margin-35.4%
WC Released (1x)$287K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.9M$-15.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.9M$-18.7M0.00x-100.0%
Bull Case9.0x11.0x$-4.4M$-18.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.4M$-21.5M0.00x-100.0%
Bear Case11.0x10.0x$-5.4M$-16.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.4M$-20.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (34.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 66.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 99 hospitals with 8-30 beds
  • Same-state prioritization (n=102)
  • Comp margins: P25=-31.1% / P50=-20.7% / P75=-12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.